Clinical trial
Congestive Heart Failure Outreach Program
NCT00371085 · University of Alberta, Other · Completed
Key facts
| NCT number | NCT00371085 |
|---|---|
| Title | Congestive Heart Failure Outreach Program |
| Official title | Congestive Heart Failure Outreach Program (The COPE Study) |
| Acronym | COPE |
| Lead sponsor | University of Alberta, Other |
| Collaborators | Heart and Stroke Foundation of Canada Merck Frosst Canada Ltd. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Behavioral |
| Interventions | education |
| Enrollment | 539 |
| Start date | Oct 1, 2004 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Sep 1, 2006 |
| Last update posted | Sep 23, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: